Decision Making for Selection of Transarterial Locoregional Therapy of Metastatic Neuroendocrine Tumors.

about

Decision Making for Selection of Transarterial Locoregional Therapy of Metastatic Neuroendocrine Tumors.

Item

http://www.wikidata.org/entity/Q39349632

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Decision Making for Selection ...... astatic Neuroendocrine Tumors.

@en

Decision Making for Selection ...... astatic Neuroendocrine Tumors.

@nl

type

Item

label

Decision Making for Selection ...... astatic Neuroendocrine Tumors.

@en

Decision Making for Selection ...... astatic Neuroendocrine Tumors.

@nl

prefLabel

Decision Making for Selection ...... astatic Neuroendocrine Tumors.

@en

Decision Making for Selection ...... astatic Neuroendocrine Tumors.

@nl

P1476

Decision Making for Selection ...... astatic Neuroendocrine Tumors.

@en

P2093

Ali Kord Valeshabad

http://www.w3.org/2001/XMLSchema#string

Andrew J Lipnik

http://www.w3.org/2001/XMLSchema#string

Joseph D Morrison

http://www.w3.org/2001/XMLSchema#string

Nasya Mendoza-Elias

http://www.w3.org/2001/XMLSchema#string

Ron C Gaba

http://www.w3.org/2001/XMLSchema#string

P2860

Toxicity and response criteria of the Eastern Cooperative Oncology Group

Quality improvement guidelines for transhepatic arterial chemoembolization, embolization, and chemotherapeutic infusion for hepatic malignancy.

Sunitinib malate for the treatment of pancreatic neuroendocrine tumors.

A 5-decade analysis of 13,715 carcinoid tumors.

Everolimus for advanced pancreatic neuroendocrine tumors.

Role of hepatic intra-arterial therapies in metastatic neuroendocrine tumours (NET): guidelines from the NET-Liver-Metastases Consensus Conference.

Radioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomes

Hepatic neuroendocrine metastases: chemo- or bland embolization?

Phase II study of chemoembolization with drug-eluting beads in patients with hepatic neuroendocrine metastases: high incidence of biliary injury.

Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients.

P304

101-108

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1055/S-0037-1602590

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28579677

http://www.w3.org/2001/XMLSchema#string

P932

5453770

http://www.w3.org/2001/XMLSchema#string